Clinical Trial Update: Intravenous Immunoglobulin and Plasma Exchange in Myasthenia Gravis [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated intravenous immunoglobulin (IVIG) and plasma exchange for myasthenia gravis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Myasthenia Gravid | Phase 4 | Status: COMPLETED